by Robert Grant | Apr 15, 2015
Dear Bob, I am a research educator and advocate that has done and continues to do a lot of work around PrEP. I believe I heard you say that not one case anywhere had been identified where a patient who had blood levels consistent with daily dosing seroconverted. Is my...
by Robert Grant | Apr 15, 2015
Dear Bob, I am a heterosexual male and I recently began taking PrEP. Are there any research studies that will be able to assess if Truvada is effective for people who don’t use condoms? I use condoms but there are times when they break or slip off without a...
by Robert Grant | Apr 15, 2015
Dear Bob, From what I have learned, Truvada has two drugs that work to stop reverse transcriptase. If the HIV virus has a mutation that causes one drug to be ineffective, the other drug still has a chance to stop it. My question: Wouldn’t it be theoretically...
by Robert Grant | Apr 15, 2015
Dear Bob, Do researchers know enough about the lifecycle of HIV as it enters the body and how this pertains to Truvada in the bloodstream? For example, in its lifecycle, will HIV always encounter the Truvada in the bloodstream before it can start an infection? Or can...
by Robert Grant | Feb 13, 2015
CDC recommends that PrEP be considered for people who are HIV-negative and at substantial risk for HIV. For sexual transmission, this includes anyone who is in an ongoing relationship with an HIV-positive partner. It also includes anyone who is not in a mutually...
Recent Comments